一种新的实用决策规则:在乳腺超声上更好地区分BI-RADS 3类与4类乳腺肿块
该研究基于国际多中心试验(NCT02638935)纳入的1294例常规B超评估为BI-RADS 3或4类的女性,由三位专家医师按BI-RADS评估图像,以组织病理学为参考标准。多因素分析显示年龄≥50岁、非局限/模糊边缘、微小分叶边缘、非平行方位和钙化与恶性显著相关(P<.05)。据此制定的决策规则敏感度97%,高于三位专家(79-95%)和既往决策规则(59%),特异度44%(对比22-83%)。
要点
- 年龄≥50岁或具备钙化、非平行方位、非局限边缘、后方声影任一特征时,应行诊断性活检(BI-RADS 4类)而非随访影像(BI-RADS 3类)。
- 决策规则敏感度97%,漏诊癌少于三位专家(敏感度79-95%)和既往决策规则(敏感度59%)。
- BI-RADS描述词及最终BI-RADS评分的阅片者间信度为一般至中等。
核心结论
- 患者年龄≥50岁或出现钙化、肿块非平行方位、非局限边缘或后方声影中至少一个特征时,应行诊断性活检(BI-RADS 4类)而非随访影像(BI-RADS 3类)。
研究设计与样本
- 国际多中心试验(NCT02638935)纳入1294例女性(排除6例),常规B超评估为BI-RADS 3或4类,由三位专家医师按BI-RADS评估超声图像,全部患者经组织病理学确认(参考标准)。
诊断标准与关键数值
- 多因素分析中与恶性显著相关的描述词(P<.05):年龄≥50岁(OR 8.99)、非局限模糊边缘(OR 4.05)、微小分叶边缘(OR 2.95)、非平行方位(OR 2.69)、钙化(OR 2.64);组织病理学证实1288个肿块中368个为恶性(28.6%)。
临床应用与阅片要点
- 决策规则敏感度97%,漏诊癌少于三位专家(敏感度范围79-95%)和既往决策规则(敏感度59%);特异度44%,对比三位专家和既往决策规则的特异度范围22-83%。
局限性
- BI-RADS描述词及最终BI-RADS评分的阅片者间信度为一般至中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The BI-RADS classification provides a standardized way to describe ultrasound findings in breast cancer diagnostics. However, there is little information regarding which BI-RADS descriptors are most strongly associated with malignancy, to better distinguish BI-RADS 3 (follow-up imaging) and 4 (diagnostic biopsy) breast masses.
METHODS: Patients were recruited as part of an international, multicenter trial (NCT02638935). The trial enrolled 1294 women (6 excluded) categorized as BI-RADS 3 or 4 upon routine B-mode ultrasound examination. Ultrasound images were evaluated by three expert physicians according to BI-RADS. All patients underwent histopathological confirmation (reference standard). We performed univariate and multivariate analyses (chi-square test, logistic regression, and Krippendorff's alpha).
RESULTS: Histopathologic evaluation showed malignancy in 368 of 1288 masses (28.6%). Upon performing multivariate analysis, the following descriptors were significantly associated with malignancy (P < .05): age ≥50 years (OR 8.99), non-circumscribed indistinct (OR 4.05) and microlobulated margin (OR 2.95), nonparallel orientation (OR 2.69), and calcification (OR 2.64). A clinical decision rule informed by these results demonstrated a 97% sensitivity and missed fewer cancers compared to three physician experts (range of sensitivity 79-95%) and a previous decision rule (sensitivity 59%). Specificity was 44% versus 22-83%, respectively. The inter-reader reliability of the BI-RADS descriptors and of the final BI-RADS score was fair-moderate.
CONCLUSIONS: A patient should undergo a diagnostic biopsy (BI-RADS 4) instead of follow-up imaging (BI-RADS 3) if the patient is 50 years or older or exhibits at least one of the following features: calcification, nonparallel orientation of mass, non-circumscribed margin, or posterior shadowing.
引用
- Pfob A, Barr RG, Duda V, et al. A New Practical Decision Rule to Better Differentiate BI-RADS 3 or 4 Breast Masses on Breast Ultrasound. J Ultrasound Med. 2021. PMID: 33942358. doi:10.1002/jum.15722
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。